Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

LBBAP limits hospital readmissions after TAVR
Left bundle branch area pacing is associated with better long-term outcomes than traditional right ventricular pacing when patients require PPMI after TAVR, according to new research in Heart Rhythm.
FDA approves Boston Scientific leads for left bundle branch area pacing
Boston Scientific's INGEVITY+ pacing leads were originally approved by the FDA back in 2019. They can now be used for LBBAP, a new alternative to biventricular pacing.
JACC editor excited by progress during a 'very important moment' for cardiology
Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.
FDA approves Biotronik lead, catheter for left bundle branch area pacing
LBBAP is a relatively new alternative to biventricular pacing. The FDA's decision was based largely on data from the BIO-CONDUCT clinical trial.
Surgeons make history, perform world’s first fully robotic heart transplant
The procedure, which lasted roughly two and half hours, was performed on a 16-year-old patient with end-stage heart failure.

FDA announces another recall for troubled heart device after multiple hospitalizations

This latest recall involves the device's driveline boot cover, which “can become stiff over time” and cause problems for clinicians. There have been 33 complaints since 2017 related to the issue.

December 2, 2022

High copays keep many heart failure patients from filling needed prescriptions

Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association.

December 1, 2022

Adding extra salt to your food at the table associated with a greater risk of CVD, heart failure

Yes, even a little additional salt can make a big impact on a person's cardiovascular health. The full analysis was published in the Journal of the American College of Cardiology.

November 28, 2022

The power of AI: Advanced algorithm IDs heart issues using Apple Watch data

A team of Mayo Clinic specialists led the analysis, sharing their findings in Nature Medicine.

November 23, 2022

Abiomed’s Impella RP Flex with SmartAssist heart pump has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of acute right heart failure for up to 14 days.

Surgeons make history, become first in world to implant Abiomed’s new heart pump for right heart failure

Two specialists with Hackensack University Medical Center in New Jersey performed the procedure. The patient, a 71-year-old woman, is doing well.

November 22, 2022

Tracking the health benefits of influenza vaccines: ‘If you have heart failure, you should get your flu shot’

The new analysis focused on data from more than 5,000 heart failure patients throughout Asia, the Middle East and Africa.

November 17, 2022

Image from the American Heart Association (AHA) annual scientific sessions where a large amount of late-breaking cardiology science is presented. #AHA #AHA22 #AHA2022

Links to the American Heart Association 2022 late-breaking studies

The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.

November 11, 2022

The new study, published in Current Problems in Cardiology, included data from nearly 18,000 adult patients.

November 10, 2022

Heart Failure

LBBAP limits hospital readmissions after TAVR

FDA approves Boston Scientific leads for left bundle branch area pacing

JACC editor excited by progress during a 'very important moment' for cardiology

FDA approves Biotronik lead, catheter for left bundle branch area pacing

Surgeons make history, perform world’s first fully robotic heart transplant